Small molecule thienopyrimidine-based protein tyrosine kinase inhibitors
申请人:Thrash Thomas
公开号:US20060004002A1
公开(公告)日:2006-01-05
Various thienopyrimidine-based analog compounds are able to selectively inhibit the Src family of tyrosine kinases. These compounds are useful in the treatment of various diseases including hyperproliferative diseases, hematologic diseases, osteoporosis, neurological diseases, autoimmune diseases, allergic/immunological diseases, or viral infections.